Newborns With Cystic Fibrosis Have Gene Variations That Could Cause Intestinal Blockage

by Kathy Jones on  April 2, 2012 at 9:05 PM Child Health News   - G J E 4
Several regions of the genome that may predispose cystic fibrosis (CF) patients to develop an intestinal blockage even while in the womb have been identified by University of North Carolina at Chapel Hill researchers working as part of the International Cystic Fibrosis Consortium.
 Newborns With Cystic Fibrosis Have Gene Variations That Could Cause Intestinal Blockage
Newborns With Cystic Fibrosis Have Gene Variations That Could Cause Intestinal Blockage

A report of this international study appears online April 1, 2012 in the journal Nature Genetics. It was the work of the North America CF Gene Modifier Consortium, which brought together dozens of investigators from the United States, Canada, and from France, to identify genetic variations that could be linked with meconium ileus (MI), an intestinal obstruction that usually requires emergency surgery for treatment, and can result in a substantially increased rate of serious health problems.

MI affects roughly 15-20 percent of all patients with CF, a genetic condition that causes scarring throughout the body, especially the lungs and pancreas. Though every CF patient carries mutations in both copies of the same gene - coding for a protein called cystic fibrosis transmembrane conductance regulator, or CFTR - symptoms can vary widely from patient to patient.

The genome-wide association study (GWAS) of more than 3,700 CF patients identified non-CFTR genetic variants in the cell membrane that separates the interior of cells from the outside environment. More specifically, the variants involved genes responsible for ion transport in the lower end of the small intestine.

"These variants involve cells in the small intestine that predispose CF patients to develop MI while still in the womb," said one of the senior study authors Michael Knowles, MD, professor of pulmonary and critical care medicine at UNC and a member of UNC''s Cystic Fibrosis-Pulmonary Research and Treatment Center.

"The discovery provides new understanding of the pathogenic mechanisms underlying MI. In addition, it offers the possibility of developing therapies to intervene in utero," Knowles said. "Further, it provides molecular insight into the role of genetic variation in ion transporters in CF, which may be applicable to more commonly, and severely, involved organs such as the lungs."

Other UNC study coauthors are Wanda K. O''Neal, Rhonda G. Pace, Jaclyn R. Stonebraker, Sally D. Wood, and Fred A. Wright. In the U.S., the study was funded by the National Heart, Lung and Blood Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, and the U.S. Cystic Fibrosis Foundation.

Source: Newswise

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

View All